Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS26P3, also known as ribosomal protein S26 pseudogene 3, is a pseudogene in the human genome. Pseudogenes are segments of DNA that resemble functional genes but are generally regarded as non-functional due to mutations that prevent them from being transcribed into functional proteins. RPS26P3 does not encode an active ribosomal protein and therefore does not share the structural or biological functions attributed to the functional RPS26 gene or protein. The canonical ribosomal protein S26 (RPS26) is a component of the 40S ribosomal subunit, involved in protein synthesis, and mutations in RPS26 are implicated in Diamond-Blackfan anemia, but RPS26P3 is not functionally implicated in these or any other disease processes. The functional version of this gene, RPS26, is protein-coding, while RPS26P3 is annotated as a pseudogene. Pseudogenes are numerous throughout the human genome, especially for genes encoding essential and highly expressed proteins such as ribosomal proteins. There is no evidence in genetic, pharmacological, or clinical databases of RPS26P3 being an active locus or druggable target. There is no literature describing RPS26P3 as a biomarker, nor as having any mechanism of action, disease relationship, or safety concerns. If you intended the functional ribosomal protein S26 (RPS26, not RPS26P3), see full functional data for RPS26, which is a protein-coding gene involved in ribosome assembly, protein synthesis, and associated with Diamond-Blackfan anemia. The pseudogene RPS26P3 is not clinically or pharmacologically relevant, and thus is_not a target_.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 3 (RPS26P3).